Yezan Salamoun is a 2023-2027 Self Graduate Fellow, pursuing a Ph.D. in Pharmaceutical Chemistry at the University of Kansas. Residing in Overland Park, KS, Yezan's academic journey began with a Bachelor of Science degree in Pharmaceutical Sciences in 2021, followed by the completion of a Doctor of Pharmacy degree in 2023. Yezan's research focuses on the development of a novel prodrug, aiming to bring it to preclinical pharmaceutical product status during his Ph.D. tenure. This work has recently achieved NIH funding, affirming its potential for significant pharmaceutical innovation. In prior research, Yezan studied the stability of Nitroglycerin and conducted metabolomic studies to identify a therapeutic biomarker for methotrexate. Beyond his academic pursuits, Yezan owns PRIMAL POWER, a supplement company dedicated to promoting healthy lifestyles.